Valproate Sodium Injection shortage

Valproate sodium injections are on the FDA’s drug shortage list as of Nov 21, 2026.

  • The companies reporting it blame rising demand.
  • 1 other company sells the same medicine and has not reported a problem, so your pharmacy may be able to order another company’s version.
Status
FDA term: “Current”
Products on the record
2
Companies reporting
2
Category
First posted
Dec 30, 2020
Last updated
Nov 18, 2026
Medicaid use (2026)

This page is curated, coded, and maintained by ⁠ Compiled from public FDA (openFDA) and CMS (Medicaid) data sources. Editorial policy

Source: FDA Drug Shortages Database API (openFDA). Last refreshed Nov 21, 2026 (today).

The Bottom Line

Valproate sodium injection is in a current shortage that has lasted over a year, caused by higher demand. One of the two reporting makers still lists the 500 mg/5 mL strength, and Sagent also lists a 100 mg/mL product that has no reported shortage.

Don’t stop or change your therapy on your own — ask your pharmacist about other companies’ versions (see options) and your prescriber about a long-term plan.

Is Valproate Sodium Still in Shortage? Status as of Nov 21, 2026

Yes, still current as of Nov 21, 2026. Every strength is still made by at least one company. 1 of the 2 companies that reported this shortage says it still has some supply, and 1 other company sells the same medicine and has not reported a problem. Your pharmacy may still need to order it or offer another company’s version.

Supply Risk: Low

2 of 5 risk factors

Your pharmacy can often still get it, though it may need to be ordered. It is our estimate across the country, not a check of your pharmacy’s shelves.

Which of the Five Risk Factors Apply

  • A strength with no makerAll 2 strengths on the record are still made by a company. Does not apply
  • Down to one company2 companies may still have it: 1 of the 2 companies that reported the shortage says it has supply, and 1 more has not reported a problem. Does not apply
  • Most products unavailable50% of its products on the FDA’s list are marked unavailable. Applies
  • Over three monthsOn the FDA list for about 6 years. Applies
  • Few companies make it3 companies make it: 2 that reported the shortage and 1 that has not. Does not apply

What each rating means ↓

The charts count only the companies that reported this shortage to the FDA; companies that haven’t reported a problem are listed after them, and the Supply-Risk rating counts them too.

Availability of the Affected Products

From the FDA shortage report: 2 products

  • 1
  • 1

Is Every Strength Still Made?

A medicine often comes in several strengths, and more than one company may make each. This shows whether at least one company still makes each strength on the record: a company on the shortage report that still has supply, or another company that sells it.

2 of 2 strengths

  • 100 mg/mLStill made by a company
  • 500 mg/5 mLStill made by a company

Reporting Companies With Supply

Among the 2 companies that reported this shortage — plus 1 other company listing it, below

1 of 2 reporting

Other Companies Listing the Same Medicine, Not Reporting a Shortage

Companies that list Valproate Sodium Injection with the FDA and have not reported a shortage (not counted in the charts above).

  • Sagent Pharmaceuticals

Plus 6 other dosage forms of valproate sodium.

See all other options & details ↓

Shortage Timeline

  1. Nov 18, 2026 Currently in shortage 2 of 2 products affected.
  2. Oct 14, 2026 FDA refreshed this shortage record 1 product updated.
  3. Dec 30, 2020 First reported to the FDA 2 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

Which Valproate Sodium Products Are Affected, by Company

Only the companies that told the FDA about a supply problem are listed here, so other companies may still have stock (see Where else can I get valproate sodium?).

Company: Fresenius Kabi USA, LLC 1 product · 888-386-1300
  • Valproate Sodium Injection, 100 mg/mL

    63323-0494-05
    Strength
    100 mg/mL
    Availability

    Notes: Next release December 2026. Check wholesalers for inventory.

    Reason: Demand increase for the drug

Company: Hikma Pharmaceuticals USA, Inc. 1 product · 800-631-2174
  • Valproate Sodium Injection, 500 mg/5 mL

    00143-9785-10
    Strength
    500 mg/5 mL
    Availability

    Notes: Additional lots will be available. Product will be made available as it is released.

Why Is Valproate Sodium in Shortage?

A note from Dr. Brian Staiger, PharmD · Written Nov 21, 2026

Valproate sodium injection is on the FDA shortage list because of a demand increase. In plain terms, more people need it than the manufacturers expected, so supply hasn't kept up.

This report covers two products. Fresenius Kabi lists its 100 mg/1 mL valproate sodium injection (NDC 63323-494-05) as unavailable right now, and says its next release is December 2026. Hikma lists its 500 mg/5 mL injection (NDC 0143-9785-10) as available, and says more lots will be coming and will be made available as they are released.

I'll be straightforward that the report doesn't give any other cause beyond the higher demand. It also only speaks for these two manufacturers and these specific products, so it doesn't tell us about anyone else's supply.

FDA Reason Codes

What Should I Do If I Take Valproate Sodium?

A note from Dr. Brian Staiger, PharmD · Written Nov 21, 2026

Valproate sodium injection is currently on the FDA drug shortage list, and the overall supply risk is rated low. Every listed strength still has at least one possible source.

Strengths and supply:

  • 500 mg/5 mL: Hikma reports this as available, with more lots coming as they are released.
  • 100 mg/mL: Fresenius Kabi lists this as unavailable, with its next release expected in December 2026. Another maker, Sagent Pharmaceuticals, has the same medicine in this strength on record.

This shortage has lasted more than a year. The FDA lists the reason as higher demand for the drug. One of the two reporting manufacturers still has supply. This information comes from national, manufacturer-reported data, so it may not match what your local pharmacy or hospital has on hand.

What you can do:

  1. Do not stop, skip, or change your doses on your own.
  2. Ask your pharmacy or care team to order your strength. Pharmacies can check wholesalers and other manufacturers.
  3. If your usual product is out, your pharmacy may be able to get the same medicine from Sagent, though it may not be in local stock.
  4. If your product cannot be found, talk with your prescriber or pharmacist about options. A different option may not suit everyone, so it should be chosen by your care team.
  5. Manufacturer phone numbers are listed on this page for reference. Pharmacies usually handle these calls.

This is general information, not personal medical advice.

Quick checklist for the pharmacy counter

  • Ask your pharmacy to check other companies’ versions, other strengths, package sizes, and nearby stores — the options below are a starting point.
  • If this is part of an ongoing or essential regimen (for example HIV, seizure, heart, transplant, diabetes or mental-health medicines), arrange continued supply before you run out rather than rationing doses.

Where Else Can I Get Valproate Sodium?

From the current FDA NDC Directory: other valproate sodium products from the reporting companies that are not on this shortage record, the same medicine from companies that have not reported a shortage and other dosage forms.

  • Some listings are repackagers, which relabel another company’s product.
  • A listing is not stock: these may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Other Valproate Sodium Products From the Reporting Companies

The same active ingredient, dosage form and route from the reporting companies, in products that are not on this shortage record.

ProductStrengthForm / routeCompanyNDC
Valproate Sodium 100 mg/mL Injection · Intravenous Hikma Pharmaceuticals USA Inc. 00143-9637-10

Same Medicine From Other Companies (Not Reporting a Shortage)

The same active ingredient, dosage form and route, from companies that have not reported a shortage to the FDA.

ProductStrengthForm / routeCompanyNDC
Valproate Sodium 100 mg/mL Injection, Solution · Intravenous Sagent Pharmaceuticals 25021-0797-05

Therapeutic Equivalents and Pricing 5 products

Other products the FDA rates as interchangeable with the affected strengths, with what pharmacies pay for each and whether pharmacies are still buying it. Cheapest first.

ProductManufacturerPackagePharmacy cost per unit (NADAC)FDA rated equivalentAvailability
Valproate Sodium 100 mg/mLNDC 00143-9637-10 Hikma 10 vials — AP FDA listed
Valproate Sodium 500 mg/5mLNDC 00143-9785-10 Hikma 10 vials — AP FDA listed
Valproate Sodium 100 mg/mLNDC 25021-0797-05 Sagent 10 vials — AP FDA listed
Valproate Sodium 100 mg/mLNDC 63323-0494-05 Fresenius 10 vials — AP FDA listed
Valproate Sodium 100 mg/mLNDC 63323-0494-16 Fresenius 10 vials — AP FDA listed

These have the same ingredient, strength, form and route, and the FDA rates them as substitutes (an “AB” rating in its Orange Book). The price is what pharmacies pay on average (CMS’s NADAC survey), not what you pay. Availability comes from recent pharmacy prices, not a stock check.

Other Drugs in the Same Treatment Class

These are different medicines — not other versions of valproate sodium — that fall in the same broad treatment class (anticonvulsants). They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Codes & Classification for pharmacists and billers

GCN Seq No
031533
GCN
64371
HICL code
001882
Ingredient (HICL)
Valproic Acid (As Sodium Salt) (Valproate Sodium)
HIC1 code
H
Therapeutic class — broad (HIC1)
Nervous System (Except Autonomic)
HIC2 code
H4
Therapeutic class — intermediate (HIC2)
Anticonvulsants
HIC3 code
H4B
Therapeutic class — specific (HIC3)
Anticonvulsants
AHFS code
28:12.28.00
AHFS class
Gaba-Mediated Anticonvulsants
FDB label name
VALPROATE SOD 500 MG/5 ML VL
FDB brand name
Valproate Sodium
Legend status
F — Federal legend — prescription drug or device
GPI-14
72500020102020
GPI class
Valproate Sodium

Where does this data come from? Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other Neurology Shortages

Valproate sodium Shortage FAQs

Is valproate sodium still in shortage or on backorder?

Yes — as of Nov 21, 2026 the FDA lists valproate sodium injections as a current shortage (status: “Current”, first reported Dec 30, 2020). The FDA’s record for this shortage covers 2 products from 2 companies. This is national, manufacturer-reported data, so your pharmacy may still have stock.

Which strengths of valproate sodium are affected?

The FDA record covers 2 strengths: 100 mg/mL, 500 mg/5 mL. Every strength on the record is still made by at least one company, though stock varies by pharmacy.

Why is valproate sodium on backorder?

The companies reporting it blame rising demand.

Is valproate sodium discontinued?

No. No company on this FDA record has told the FDA it is discontinuing valproate sodium injections. It is listed as a shortage, which is a supply problem, not a medicine being withdrawn.

Which valproate sodium products are affected?

Valproate Sodium Injection, 100 mg/mL (NDC 63323-0494-05); Valproate Sodium Injection, 500 mg/5 mL (NDC 00143-9785-10). The full per-NDC list (availability, company and status) is in the table above — each NDC links to its own page.

When will valproate sodium be available again?

The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.

Can I still get valproate sodium somewhere?

Another company (Sagent Pharmaceuticals) sells the same medicine and has not reported a problem. 6 other dosage forms of valproate sodium are also listed. See “Where else can I get valproate sodium?” above — stock still varies by pharmacy.

What should I do if I take valproate sodium?

Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another company or a different strength or package size, and ask your prescriber about a long-term plan before your supply runs out.

How to Read the Supply-Risk Rating

Each drug in shortage gets one point for each of five risk factors that apply to it (listed with its rating). It is our estimate across the country, not a check of your pharmacy’s shelves.

  • Low0 to 2 risk factors Your pharmacy can often still get it, though it may need to be ordered.Valproate sodium is rated Low: 2 of 5 risk factors.
  • Medium3 risk factors Supply is tight in several ways. Finding it may take some calling around.
  • High4 or 5 risk factors, or no company found making it Few companies are left making it, or some strengths have no maker at all. It may be hard to find for a while.

Back to this drug’s rating ↑ · How we rate supply risk, in full

Where This Data Comes From

For reference only. Check with your pharmacist, the drug’s maker or the FDA before acting on it.

Back to all current drug shortages